couter

ABVCABVC BioPharma, Inc.

Nov 14, 2026 — Q3 2026 Earnings Release
Chart by TradingView

The schedule

  • Sat14Nov
  • Sun14Feb
  • Sat15May
  • Wed11Aug

Past

  • Wed12Aug

    Actual outcome: Bear · $0.93 at outcome

    ABVC reported Q2 2026 earnings with EPS of $0.13, exactly meeting analyst estimates. Despite the in-line bottom line, the stock closed at $0.96, well below the bear floor of $1.23. The negative price action indicates that investors were disappointed by the broader financial details or a lack of compelling forward guidance to support a higher valuation.